Professor Des R. Richardson holds the Chair of Cancer Cell Biology at the
University of Sydney, Australia, and is an National Health and Medical Research
Council of Australia (NHMRC) Senior Principal Research Fellow. He is Director of
Molecular Pharmacology and Pathology Program at the Department of Pathology
and Bosch Institute, University of Sydney. He holds also several international
posts in the universities in North America, Europe, and Asia.
His research interests span pharmacology, medicinal chemistry (drug
development), metabolism, cell biology, biochemistry, and molecular biology.
Recently, he has designed, developed and commercialised an anti-cancer agent,
DpC, that has entered multi-centre clinical trials.
Prof. Richardson published more than 400 peer-reviewed articles, chapters,
patents, etc., which have been cited > 18,000 times over his career (8500 citations
over the past 5 years; H-index: 75).